Vaxart Inc. (VXRT)
Vaxart Statistics
Share Statistics
Vaxart has 228.21M shares outstanding. The number of shares has increased by 0.23% in one year.
| Shares Outstanding | 228.21M |
| Shares Change (YoY) | 0.23% |
| Shares Change (QoQ) | 0.21% |
| Owned by Institutions (%) | 15.71% |
| Shares Floating | 222.57M |
| Failed to Deliver (FTD) Shares | 911 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 12.92M, so 5.67% of the outstanding shares have been sold short.
| Short Interest | 12.92M |
| Short % of Shares Out | 5.67% |
| Short % of Float | 5.72% |
| Short Ratio (days to cover) | 7.25 |
Valuation Ratios
The PE ratio is -19.99 and the forward PE ratio is -0.82. Vaxart's PEG ratio is 0.48.
| PE Ratio | -19.99 |
| Forward PE | -0.82 |
| PS Ratio | 46.63 |
| Forward PS | 3.1 |
| PB Ratio | 22.71 |
| P/FCF Ratio | -29.53 |
| PEG Ratio | 0.48 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Vaxart.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 0.3.
| Current Ratio | 0.75 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.3 |
| Debt / EBITDA | -0.32 |
| Debt / FCF | -0.39 |
| Interest Coverage | -22.33 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $273.33K |
| Profits Per Employee | $-637.6K |
| Employee Count | 105 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 260K |
| Effective Tax Rate | -0.39% |
Stock Price Statistics
The stock price has increased by -45.32% in the last 52 weeks. The beta is 1.57, so Vaxart's price volatility has been higher than the market average.
| Beta | 1.57 |
| 52-Week Price Change | -45.32% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 0.67 |
| Relative Strength Index (RSI) | 42.91 |
| Average Volume (20 Days) | 1.81M |
Income Statement
In the last 12 months, Vaxart had revenue of 28.7M and earned -66.95M in profits. Earnings per share was -0.03.
| Revenue | 28.7M |
| Gross Profit | 28.7M |
| Operating Income | -66.29M |
| Net Income | -66.95M |
| EBITDA | -54.87M |
| EBIT | -63.72M |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 25.23M in cash and 17.53M in debt, giving a net cash position of 7.7M.
| Cash & Cash Equivalents | 25.23M |
| Total Debt | 17.53M |
| Net Cash | 7.7M |
| Retained Earnings | -476.52M |
| Total Assets | 166.39M |
| Working Capital | -22.62M |
Cash Flow
In the last 12 months, operating cash flow was -44.76M and capital expenditures -554K, giving a free cash flow of -45.32M.
| Operating Cash Flow | -44.76M |
| Capital Expenditures | -554K |
| Free Cash Flow | -45.32M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 100%, with operating and profit margins of -230.99% and -233.27%.
| Gross Margin | 100% |
| Operating Margin | -230.99% |
| Pretax Margin | -232.36% |
| Profit Margin | -233.27% |
| EBITDA Margin | -191.18% |
| EBIT Margin | -230.99% |
| FCF Margin | -157.9% |
Dividends & Yields
VXRT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for VXRT is $3, which is 733.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $3 |
| Price Target Difference | 733.3% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Feb 14, 2018. It was a backward split with a ratio of 1:11.
| Last Split Date | Feb 14, 2018 |
| Split Type | backward |
| Split Ratio | 1:11 |
Scores
| Altman Z-Score | -4.85 |
| Piotroski F-Score | 4 |